Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

The pharmacy briefing

News & insight.

Canadian pharmacy and therapeutics news: recalls, shortages, guideline updates and developments in practice.

192 results
Regulatory Update

OCP Outlines Pharmacy Technician Changes Ahead of October 1 Controlled Substances Regulations

Health Canada's new Controlled Substances Regulations take effect October 1, replacing three separate federal instruments -- and OCP has published a comparison chart plus Health Canada is running information sessions to help pharmacists and technicians prepare for new authorities on both sides of the counter.

Sep 8, 2026 · 4 min read Read briefing
AI-generated editorial illustration created for Pharmasist.ca. Illustrative pharmacy technician workflow; not a real controlled-substance transaction.
Practice Guidance

Ontario Pharmacists Gain Nine New Minor Ailments, Technicians Gain Expanded Vaccine Authority, Effective July 1

As of July 1, 2026, Ontario pharmacists and interns can assess and prescribe for nine additional minor ailments and administer six more publicly funded vaccines, while pharmacy technicians can now administer all Schedule 3 vaccines under supervision. The Ontario College of Pharmacists has set out what changed and what training and consent steps pharmacies need in place.

Jul 1, 2026 · 2 min read Read briefing
Illustrative pharmacy photo. National Cancer Institute / Unsplash. Image source
New Drug Approvals

Health Canada Approves Sevmia, the First Generic Semaglutide for Weight Management

Health Canada has approved Apotex's Sevmia, the first generic semaglutide authorized specifically for chronic weight management, referencing Wegovy rather than the diabetes-indicated Ozempic that earlier generics referenced. Pharmacists should be ready to explain the distinction to patients as generic semaglutide products multiply across different brand references and indications.

Jun 29, 2026 · 3 min read Read briefing
Illustrative injection equipment; not the products discussed. Diana Polekhina / Unsplash. Image source
Medication Safety

Health Canada Adds Pulmonary Aspiration Warning to All GLP-1 Receptor Agonist Product Monographs

Health Canada has completed a safety review linking GLP-1 receptor agonists — including semaglutide, tirzepatide, dulaglutide, liraglutide, and lixisenatide — to an increased risk of pulmonary aspiration during general anesthesia or deep sedation, and has updated the Canadian product monographs for the entire drug class. Community and hospital pharmacists are often the last clinician to see both the medication history and the upcoming procedure.

Apr 30, 2026 · 3 min read Read briefing
Illustrative perioperative care photo. National Cancer Institute / Unsplash. Image source
Drug Shortages

Health Canada Authorizes UK and US Imports of Injectable Cyclophosphamide Amid Tier 3 Shortage

Health Canada has authorized the exceptional importation of UK- and US-labelled cyclophosphamide for injection to relieve a Tier 3 shortage of this essential chemotherapy drug, first declared in February 2026. Hospital and oncology pharmacists need to know the differences between the Canadian, UK, and US-labelled products before dispensing or preparing doses.

Apr 10, 2026 · 3 min read Read briefing
Archival IV bottle, 1980; not the UK or U.S. imports. Photo: Linda Bartlett / NCI, public domain. Resized/WebP. Image source
Medication Safety

ISMP Canada Bulletin: Near-Miss Oral Ingestion of a Boric Acid Vaginal Suppository Prompts Packaging Changes

A consumer nearly swallowed a boric acid vaginal suppository after mistaking the oral-look capsule for a vitamin, prompting ISMP Canada and manufacturer Szio+ Inc. to add explicit vaginal-use warnings to the Utiva Yeast Control packaging. Pharmacists selling this and similar non-prescription boric acid products need to counsel proactively, since these are self-selected products often sold without a pharmacist consult.

Feb 26, 2026 · 3 min read Read briefing
Illustrative medication packaging; not the product discussed. Brett Jordan / Unsplash. Image source
Medication Safety

Health Canada Recalls Two Lots of MAR-Amlodipine After Bottles Found to Contain Midodrine Tablets

Health Canada and Marcan Pharmaceuticals recalled two lots of MAR-Amlodipine 5 mg after some bottles were found to contain midodrine 2.5 mg tablets instead, a mix-up that could send a hypertensive patient's blood pressure dangerously higher or a hypotensive patient's dangerously lower. Community pharmacists need the exact lot numbers and tablet-appearance cues to check remaining stock and dispensed bottles.

Feb 7, 2026 · 2 min read Read briefing
Illustrative medications; not the recalled products. National Cancer Institute / Unsplash. Image source

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.